These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 933924)

  • 1. Aminophylline injection and theophylline tablets: Acute response in partially reversible chronic airway obstruction.
    Freitag A
    Med J Aust; 1976 Apr; 1(14):478-9. PubMed ID: 933924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative assessment of three bronchodilator preparations in general practice.
    Maneksha S
    J Int Med Res; 1979; 7 Suppl 1():62-6. PubMed ID: 437309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral aminophylline and dikydroxypropyl theophylline in reversible obstructive airway disease: a single-dose, double-blind, crossover comparison.
    Hudson LD; Tyler ML; Petty TL
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):367-72. PubMed ID: 4198297
    [No Abstract]   [Full Text] [Related]  

  • 4. Rational intravenous doses of theophylline.
    Mitenko PA; Ogilvie RI
    N Engl J Med; 1973 Sep; 289(12):600-3. PubMed ID: 4723589
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of controlled-release aminophylline (Phyllocontin Continus tablets) and sympathomimetic bronchodilators.
    Sahay JN; Chatterjee SS
    J Int Med Res; 1979; 7 Suppl 1():56-61. PubMed ID: 437308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma theophylline level and effect on lung function after oral and rectal administration of aminophylline.
    Lamont H; Moerman E; Bogaert M; Van Der Straeten M; Pauwels R
    Eur J Clin Pharmacol; 1979 Jul; 15(6):401-6. PubMed ID: 499288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind trial of oral aminophylline (Phyllocontin Continus tablets) in airflow obstruction: preliminary communication.
    Greening AP; Baillie E; Gribbin HR; Pride NB
    J Int Med Res; 1979; 7 Suppl 1():47-51. PubMed ID: 374164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Theophylline blood levels after administration of Euphyllin retard (author's transl)].
    Ahrens J
    Dtsch Med Wochenschr; 1977 Apr; 102(13):482-6. PubMed ID: 844428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative trial of combination therapy in obstructive airways disease.
    Sahay JN; Chatterjee SS
    Curr Med Res Opin; 1980; 7(1):23-7. PubMed ID: 7428409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
    Dasta J; Mirtallo JM; Altman M
    Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
    Gupta S; Raina RK; Samotra K; Gupta KL
    Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and bronchodilatory effect of proxyphylline and theophylline.
    Rasmussen FV; Waldorff S; Madsen L
    Eur J Respir Dis; 1984 Jan; 65(1):20-7. PubMed ID: 6705854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative crossover study of two long-acting bronchodilator preparations.
    Maneksha S
    Curr Med Res Opin; 1976; 4(3):207-11. PubMed ID: 780061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
    Hirsch H
    Wien Med Wochenschr; 1983 Aug; 133(15-16):403-8. PubMed ID: 6636797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bronchodilator action of theophylline aerosol in subjects with chronic airflow obstruction.
    Bohadana AB; Peslin R; Teculescu D; Polu JM; Belleville F; Massin N
    Bull Eur Physiopathol Respir; 1980; 16(1):13-24. PubMed ID: 7357122
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of intravenous furosemide on serum theophylline concentration.
    Conlon PF; Grambau GR; Johnson CE; Weg JG
    Am J Hosp Pharm; 1981 Sep; 38(9):1345-7. PubMed ID: 7282719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of theophylline clearance in determining chronic oral dosage regimens.
    Slotfeldt ML; Johnson CE; Grambau G; Weg JG
    Am J Hosp Pharm; 1979 Jan; 36(1):66-8. PubMed ID: 758787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theophylline serum concentration and therapeutic effect in severe acute bronchial obstruction: the optimal use of intravenously administered aminophylline.
    Vozeh S; Kewitz G; Perruchoud A; Tschan M; Kopp C; Heitz M; Follath F
    Am Rev Respir Dis; 1982 Feb; 125(2):181-4. PubMed ID: 7065521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative examination of theophylline-serum-concentrations and bronchospasmolytic effect of cholintheophyllinate (euspirax) and theophyllin-aethylendiamine (euphyllin retard) in patients with obstructive airway diseases (author's transl)].
    Wettengel R; Oellerich M; Schnitker J
    Prax Klin Pneumol; 1979 Nov; 33(11):1125-31. PubMed ID: 523424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.